Construct validity of medicare chemotherapy claims: the case of 5FU.

  title={Construct validity of medicare chemotherapy claims: the case of 5FU.},
  author={Elizabeth Lamont and Diane S. Lauderdale and Richard L. Schilsky and Nicholas A. Christakis},
  journal={Medical care},
  volume={40 3},
BACKGROUND The elderly are under represented in clinical trials of cancer therapy and the elderly who are enrolled may be unrepresentative. OBJECTIVE To assess whether Medicare claims data might be used to understand the benefits and tolerance of chemotherapy in the general elderly population, the construct validity of Medicare 5FU claims for elderly colon cancer patients within the SEER-Medicare data set was determined. METHODS In this validation study of Medicare chemotherapy claims from… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 19 extracted citations

Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2012
View 2 Excerpts


Publications referenced by this paper.
Showing 1-10 of 43 references

Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2001

Similar Papers

Loading similar papers…